TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003.

Philip C Mack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.